Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox pelvic floor injection for chronic pelvic pain
ACTRN12620000067976Phase 2Completed
- Sponsor
- Mercy
- Start
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in chronic prostatitis (CP), sponsored by Mercy. Started Jul 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on ACTRN12620000067976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000067976.